Archives
ACR: Genicular Nerve Block Offers Short-Term Pain Relief for Knee OA
Improvements seen in pain scores for patients receiving genicular nerve block at two, four, eight, and 12 weeks
ACR: Opioids Raise Risk for VTE in Patients With Rheumatoid Arthritis
However, opioids and NSAIDs carry similar cardiovascular, mortality risks for RA patients
ACR: Long-Term Safety Demonstrated for Anifrolumab in Lupus
Exposure-adjusted incidence rates of serious adverse events 8.5 versus 11.2 per 100 patient-years for anifrolumab versus placebo
ACR: Holding Methotrexate for Just a Week After Flu Vaccine Works for RA Patients
Authors say immune response similar for patients holding methotrexate for one week or two weeks
ACR: Low-Dose Hydroxychloroquine Tied to More Hospitalizations for Lupus Flares
Both weight-based and non-weight-based low-dose HCQ associated with increased hospitalizations for SLE
ACAAI: Epinephrine Auto-Injector Use Low Among Adults With Food Allergy
Furthermore, one-third of adults with food allergy think epinephrine auto-injectors can cause life-threatening effects
AHA: Other Defibrillation Strategies Studied for Refractory V-Fib
Survival to hospital discharge higher with use of double sequential external defibrillation compared with standard defibrillation
ASN: Empagliflozin Cuts Risk for Progression in CKD
Risk for progression of kidney disease or death from cardiovascular causes reduced with empagliflozin versus placebo
ASN: Discontinuation of RAS Inhibitors Does Not Increase eGFR in CKD
No difference seen with discontinuation, continuation of RAS inhibitors among patients with advanced, progressive chronic kidney disease
AHA: Strategies Compared for Treating Chronic Limb-Threatening Ischemia
Outcomes better for surgical revascularization versus endovascular therapy for those with single segment of great saphenous vein that could be used for surgery
